PERSONALISED DIAGNOSTICS LIMITED

Company Registration Number:
13124636 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2023

Period of accounts

Start date: 01 February 2023

End date: 31 December 2023

PERSONALISED DIAGNOSTICS LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2023

Balance sheet
Notes

PERSONALISED DIAGNOSTICS LIMITED

Balance sheet

As at 31 December 2023


Notes

31 December 2023

31 January 2023


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets: 3 101,063 99,230
Investments: 4 384,365 384,365
Total fixed assets: 485,428 483,595
Current assets
Debtors:   156,475 274,765
Cash at bank and in hand: 57,592 122,769
Total current assets: 214,067 397,534
Creditors: amounts falling due within one year:   (383,148) (238,384)
Net current assets (liabilities): (169,081) 159,150
Total assets less current liabilities: 316,347 642,745
Total net assets (liabilities): 316,347 642,745
Capital and reserves
Called up share capital: 3 1
Share premium account: 708,364 513,564
Profit and loss account: (392,020) 129,180
Shareholders funds: 316,347 642,745

The notes form part of these financial statements

PERSONALISED DIAGNOSTICS LIMITED

Balance sheet statements

For the year ending 31 December 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 05 September 2024
and signed on behalf of the board by:

Name: Clive Minihan
Status: Director

The notes form part of these financial statements

PERSONALISED DIAGNOSTICS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

PERSONALISED DIAGNOSTICS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

2. Employees

31 December 2023 31 January 2023
Average number of employees during the period 8 10

PERSONALISED DIAGNOSTICS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

3. Intangible Assets

Total
Cost £
At 01 February 2023 99,230
Additions 1,833
At 31 December 2023 101,063
Net book value
At 31 December 2023 101,063
At 31 January 2023 99,230

PERSONALISED DIAGNOSTICS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

4. Fixed investments

Investment in subsidiary